BRC Director Professor Bryan Williams opened a unique event this month which sought to give the MedTech industry opportunity to connect with BRCs in London, Oxford and Cambridge.
A new drug that causes less side effects than the standard treatment has been found to reduce the severity of trigeminal neuralgia, a sudden severe facial pain, according to research published in the Lancet Neurology.
Evidence of chronic traumatic encephalopathy, a potential cause of dementia caused by repeated blows to the head, has been found in the brains of former association football players examined at the UCL Queen Square Brain Bank.
UCLH is one of five European academic hospitals that make up Nightingale, a project awarded over €5 million to challenge industry to develop wireless, wearable technology to monitor patients in the ward and at home.
UCLH has recruited the first patient in Europe to a major new study to see if a combination of cancer drugs can benefit patients with a rare bone cancer.